Quantitative myelin water imaging using short TR adiabatic inversion recovery prepared echo-planar imaging (STAIR-EPI) sequence

1. Introduction

Myelin is a lipid-protein bilayer that surrounds the axonal fibers of neurons (1). It plays an essential role in normal brain function by facilitating the rapid conduction of action potentials in the axon (2). Many neurological and degenerative diseases, such as multiple sclerosis (MS), are characterized by myelin damage and loss (3, 4). Thus, evaluations of demyelination and remyelination are essential for the accurate diagnosis and treatment monitoring of these diseases. Conventional magnetic resonance imaging (MRI) techniques, such as T₁- and T₂-weighted fast spin echo (T₁w- and T₂w-FSE), provide high soft-tissue contrast and are routinely used in the diagnosis of MS and many other neurological diseases. However, these clinical sequences are unable to distinguish demyelination lesions, such as those observed in MS, from the ones caused by inflammation, edema, axonal loss, or gliosis (5–7). Moreover, it is also difficult for clinical MRI to detect myelin damage in brains that appear to be normal (i.e., where there are no apparent lesions) (8). Consequently, developing myelin-specific imaging techniques is of critical importance to improved evaluation of neurological diseases in clinical practice.

In the last two decades, many myelin water imaging (MWI) techniques have been developed for the specific evaluation of myelin changes. Myelin water (MW) is the water component tightly bound or trapped in the myelin bilayer (9–14). It has much shorter T₁ and T₂ relaxation times than intracellular/extracellular water. Myelin water fraction (MWF), defined as the signal ratio of MW to total water, is the biomarker used to quantify MW content changes (15–18).

State-of-the-art MWI techniques like multi-echo spin echo T₂ relaxometry (15), multicompartment analysis of T₂* decay (16), and multicomponent-driven equilibrium single-pulse observation of T₁ and T₂ (mcDESPOT) (17) have been developed to quantify MWF and have been applied for the assessment of MS. The high correlation between the MRI-measured MWF and histologically quantified myelin content has been demonstrated in brain sample studies (19, 20). Moreover, all these techniques are able to detect significant MWF decreases in demyelinated lesions in patients with MS in comparison to the normal white matter (NMW) in healthy individuals (15–17, 21, 22). Despite the success of these myelin-specific techniques, studies have found that these multicompartment modeling techniques are sensitive to system flaws such as B₁ and B₀ inhomogeneities (23–27). Different data post-processing strategies may also produce different results (28–31). Consequently, these techniques suffer from limited accuracy and robustness in terms of MWF estimation, shortcomings that slow down their clinical translation.

Another promising technique that has been developed for selective imaging of MW, known as direct visualization of short transverse relaxation time component (ViSTa), is based on the T₁ difference between MW and long T₂ intracellular/extracellular water components (32). The T₁ relaxation times for the long T₂ components in white matter and gray matter range from 750 to 1,000 ms and from 1,300 to 1,800 ms, respectively, at 3T (32–34). In contrast, the T₁ relaxation times for MW components are typically shorter than 600 ms (17, 18, 35, 36). This technique employs a double inversion recovery (DIR) preparation to robustly suppress all the long T₁ water components in the brain. Moreover, not only is ViSTa less sensitive to B₁ and B₀ inhomogeneities, but it does not require any complicated modeling to quantify MWF. That being said, ViSTa's scan time is too long for clinical use for whole brain coverage (∼3 min per slice).

Most recently, Ma et al. have developed a short TR adiabatic inversion recovery (STAIR) technique in combination with a 3D Cones acquisition (STAIR-Cones) for time-efficient selective MWI in the whole brain (37). This technique uses a short TR to suppress long T₁ water components with a variety of T₁s. Similar to ViSTa, the STAIR sequence is relatively insensitive to B₁ and B₀ inhomogeneities because it uses an adiabatic full passage (AFP) pulse for signal inversion; however, because the 3D Cones sequence is not a clinically available sequence (it is primarily available in GE research scanners), the STAIR-Cones sequence is currently limited in its potential for clinical translation.

In this study, we proposed a new clinically translational MWI sequence for whole-brain MWI and quantification, which is a combination of the STAIR technique and echo-planar imaging (EPI) readout. Unlike the research-dedicated Cones sequence, the EPI sequence is a routinely used clinical sequence that is available to all vendors, posing the proposed STAIR-EPI as a technique with greater potential in clinical translation than STAIR-Cones. Moreover, similar to the ViSTa and STAIR-Cones techniques, the proposed STAIR-EPI does not require complicated post-processing such as solving the ill-conditioned problems for those multicompartment modeling techniques (15–17). We investigated the feasibility of the proposed STAIR-EPI technique for the quantification of MWF and compared its values in the lesions and normal-appearing white matter (NAWM) of seven MS patients against the values of NWM of seven healthy volunteers on a clinical 3 T MRI scanner.

2. Materials and methods

2.1. STAIR-EPI sequence

Figure 1 shows a diagram of the STAIR-EPI sequence. After an AFP pulse and duration of longitudinal magnetization recovery, a blipped multi-shot EPI is used for fast data acquisition. The EPI starts with a 90° radiofrequency (RF) excitation pulse. Inversion time (TI) is determined as the time interval between the center of AFP to the center of the excitation pulse. A short TR between 180 and 300 ms is typically used in the STAIR sequence and, with an appropriate TI (37), signals from long T₁ water components with a broad range of T₁s (in this case, 600–2,000 ms) can be well suppressed.

FIGURE 1

Figure 1. Sequence diagrams for the STAIR-EPI sequence. An AFP pulse and a short TR (e.g., 250 ms) together with an optimized TI in STAIR-EPI enables robust long T₁ water suppression. The EPI allows fast data acquisition of the remaining MW signals.

The signal equation for the STAIR-EPI sequence is expressed as follows:

$S_{\mathit{S}\mathit{T}\mathit{A}\mathit{I}\mathit{R}}=M_0(1-\mathit{Q}{\mathit{e}}^{-\mathit{T}\mathit{R}/T_1}-(1-Q)e^{-\mathit{T}\mathit{I}/T_1})e^{-\frac{\mathit{T}\mathit{E}}{T_2^{\ast }}}.(1)$

$M_0=[M_0^{\mathrm{MW}},M_0^L]$ are the longitudinal magnetizations of MW and long T₁ water components in the equilibrium state. $S_{\mathrm{STAIR}}=[S_{\mathrm{STAIR}}^{\mathrm{MW}},S_{\mathrm{STAIR}}^L]$ are the signal intensities of MW and long T₁ water components in STAIR-EPI imaging. Q represents the inversion efficiency for the AFP pulse with a range of −1 (full inversion) to 1 (no disturbance to the z-magnetization). For long T₁ water components, Q is assumed to be −1. However, for MW with a short T₂* of 10 ms, Q is set to −0.75 (i.e., $Q_{\mathrm{MW}}=0.75$) when a relatively long AFP pulse (i.e., 8.64 ms) is utilized for signal inversion based on Bloch simulation (37–40). Our previous numerical simulation demonstrated that a TR range of [180, 300] ms provides a reasonable contrast-to-noise ratio (CNR) efficiency in STAIR MWI (37). Similar to the STAIR-Cones for MWI, a TR of 250 ms was selected for STAIR-EPI imaging in this study. The corresponding optimal TI (i.e., $\mathrm{T}{\mathrm{I}}_{\mathrm{optimal}}$) of the STAIR-EPI sequence is determined by minimizing the signals of long T₁ components with a wide range of T₁ values [i.e., (600, 2,000)ms] [see Equation (11) in Ref. (37)]. With the determined $\mathrm{T}{\mathrm{I}}_{\mathrm{optimal}}$, the MW signal can be expressed as follows:

$S_{\mathit{S}\mathit{T}\mathit{A}\mathit{I}\mathit{R}}^{\mathit{M}\mathit{W}}=M_0^{\mathit{M}\mathit{W}}(1-Q_{\mathit{M}\mathit{W}}{e}^{-\mathit{T}\mathit{R}/T_1}-(1-Q_{\mathit{M}\mathit{W}})e^{-\mathit{T}{\mathit{I}}_{\mathit{o}\mathit{p}\mathit{t}\mathit{i}\mathit{m}\mathit{a}\mathit{l}}/T_{1,\mathit{M}\mathit{W}}})e^{-\frac{\mathit{T}\mathit{E}}{T_{2,\mathit{M}\mathit{W}}^{\ast }}}.(2)$

$T_{1,\mathrm{MW}}$ and $T_{2,\mathrm{MW}}^{\ast }$ are $T_1$ and $T_2^{\ast }$ of MW respectively. To facilitate the quantification of apparent MWF (aMWF), a proton density-weighted EPI (PD-EPI) sequence is also scanned for total water imaging. The signal equation of the PD-EPI sequence is expressed as follows:

$S_{\mathit{P}\mathit{D}}=M_0^{\mathit{t}\mathit{o}\mathit{t}\mathit{a}\mathit{l}}{e}^{-\frac{\mathit{T}\mathit{E}}{T_{2,\mathit{t}\mathit{o}\mathit{t}\mathit{a}\mathit{l}}^{\ast }}}.(3)$

$M_{0,\mathrm{total}}$ and $T_{2,\mathrm{total}}^{\ast }$ are the equilibrium longitudinal magnetization and $T_2^{\ast }$ of total water respectively.

aMWF is defined as the PD ratio of MW to total water, and is expressed as follows:

$\mathit{a}\mathit{M}\mathit{W}\mathit{F}={\displaystyle \frac{M_0^{\mathit{M}\mathit{W}}}{M_0^{\mathit{t}\mathit{o}\mathit{t}\mathit{a}\mathit{l}}}.}(4)$

With known signal intensities of MW and total water (i.e., $S_{\mathrm{STAIR}}^{\mathrm{MW}}$ and $S_{\mathrm{PD}}$), the aMWF can be easily computed by the division operation between Equations (2) and (3). The T₁ and T₂* values of MW ($T_{1,\mathrm{MW}}$ and $T_{2,\mathrm{MW}}^{\ast }$) are set to 220 and 10 ms respectively (16–18, 23, 35, 36). The T₂* of total water ($T_{2,\mathrm{total}}^{\ast }$) is set to 60 ms (16, 23).

2.2. In vivo study

This study was approved by our institutional review board (IRB) and informed consent was obtained from all participants. Seven healthy volunteers (mean age: 39.9 ± 15.9 years, 3 males and 4 females) and seven MS patients (mean age: 53.7 ± 8.7 years, 2 males and 5 females) were recruited and underwent MRI scans. The inclusion criteria for the disease group included a documented diagnosis of MS and age over 18; exclusion criteria included concomitant malignancy and other severe diseases like stroke. The inclusion criteria for healthy volunteers were that participants were in good health and over 18 years old. All individuals with any contraindications for MRI were excluded from study participation.

All participants were scanned on a 3 T clinical MRI scanner (MR750, GE Healthcare Technologies, Milwaukee, WI) and a 12-channel head coil was employed for signal reception.

The sequence parameters of the STAIR-EPI and PD-EPI sequences were as follows: i) STAIR-EPI: field of view (FOV) = 22 × 22 cm², matrix = 128 × 128, TR/TI/TE = 250/117/5.5 ms, flip angle (FA) = 90°, number of shots = 8, slice thickness = 5 mm, number of slices = 15, number of excitations (NEX) = 30, and scan time = 15 min; (ii) PD-EPI: FOV = 22 × 22 cm², matrix = 128 × 128, TR/TE = 250/5.5 ms, FA = 5°, slice thickness = 5 mm, number of slices = 15, NEX = 10, and scan time = 43s. A clinical T₂-FLAIR sequence included for diagnosis was scanned with the following parameters: FOV = 25.6 × 25.6 × 16.3 cm³, matrix = 256 × 256 × 136, TR/TI/TE = 7,000/2,028/130 ms, acceleration factor = 4, and scan time = 5.5 min.

2.3. Data analysis

MS lesion regions in MS patients (a total of 66 lesions) and eight non-lesion white matter regions in healthy volunteers (i.e., NWM) and MS patients (i.e., NAWM) were manually drawn for aMWF quantification. The non-lesion regions included the left and right centrum semioval, subcortical white matter, periventricular regions, splenium, and genu of the corpus callosum (see Figure 2). Region of interest (ROI) drawings and aMWF calculations were both performed on MATLAB 2022a software (MathWorks Inc., Natick, MA, USA).

FIGURE 2

Figure 2. Representative non-lesion ROIs (orange ovals) of the eight WM regions including the left and right centrum semioval, subcortical white matter, periventricular regions, splenium, and genu of the corpus callosum for healthy volunteers and MS patients.

A comparison of aMWF measurement was made between NWM in healthy volunteers, NAWM in MS patients, and MS lesions in MS patients. Upon confirming normal distribution through the Kolmogorov-Smirnov test, a one-way ANOVA test was carried out to assess the differences in aMWF among these three groups (i.e., NWM, NAWM, and MS lesions). A post hoc test (Games-Howell test) was conducted for paired comparisons between each of the two groups (i.e., NWM vs. NAWM, NWM vs. MS lesions, and NAWM vs. MS lesions). P values less than 0.05 indicates statistical significance.

3. Results

Figure 3 shows the representative STAIR-EPI and PD-EPI images as well as corresponding aMWF maps from a 31-year-old male healthy volunteer. Much higher MW signal intensities in the STAIR-EPI images are found in white matter regions than those in grey matter regions. The aMWF maps also demonstrate a higher aMWF in the white matter region than in the grey matter region.

FIGURE 3

Figure 3. Representative STAIR-EPI (columns 1 and 2) and PD-EPI (columns 3 and 4) images, as well as the corresponding aMWF maps (columns 5 and 6) from a 31-year-old healthy male volunteer. White matter regions have a much higher myelin water content than gray matter regions.

Figure 4 shows representative T₂-FLAIR, PD-EPI, and STAIR-EPI images as well as aMWF maps from three MS patients. The hyperintense lesions in T₂-FLAIR show low signal intensities in the STAIR-EPI images and also have lower aMWF values than NAWM regions, demonstrating a decrease in MW content for these MS lesions.

FIGURE 4

Figure 4. Representative STAIR-EPI (first column), PD-EPI (second column), and aMWF (third column), as well as T₂-FLAIR (fourth column) from three patients with MS (patient #1 is a 57-year-old female, patient #2 is a 52-year-old male, and patient #3 is a 67-year-old female). Hyperintense lesions detected on T₂-FLAIR images (arrows) show a signal loss on the corresponding myelin water images and aMWF maps.

Table 1 summarizes the mean and standard deviation (SD) values of the aMWF measurements from all participants. The aMWF value of NWM in healthy volunteers is 10 ± 1.3%, while the aMWF values of NAWM and MS lesions in MS patients are 8.6 ± 1.2% and 3.6 ± 1.3%, respectively. Significant difference is achieved between these three groups (p < 0.001).

TABLE 1

Table 1. Mean and standard deviation (SD) of aMWF measurements from NWM, NAWM, and MS lesions as well as one-way ANOVA test results for these three groups.

Figure 5 shows the paired comparison of measured aMWF values on each of the two groups (i.e., NWM vs. NAWM, NWM vs.MS lesions, and NAWM vs. MS lesions). The results indicate a notable distinction of aMWF measurements between MS lesions against both NAWM and NWM (p < 0.001). A significant difference in aMWF measurement is also observed between NAWM and NWM (p < 0.001). These results demonstrate the feasibility of the STAIR-EPI technique in the detection of demyelination in MS.

FIGURE 5

Figure 5. Paired comparisons of aMWF measurements between NWM, NAWM, and MS lesions. The individual data points for each group are also shown in the bar plots. Significantly lower aMWF values are found in both MS lesions and NAWM regions in MS patients in comparison with NWM in healthy volunteers. (“***” indicates p < 0.001).

4. Discussion

In this study, we developed a new translational STAIR-EPI sequence for selective MWI and aMWF quantification in the whole brain. In MS patients, the hyperintense MS lesions in T₂-FLAIR showed low signal intensities in the STAIR-EPI images, indicating high sensitivity in the detection of demyelination for the STAIR-EPI technique. Moreover, the measured aMWF values of MS lesions (3.6 ± 1.3%) and NAWM (8.6 ± 1.2%) in MS patients were significantly lower than those of NWM (10 ± 1.3%) in healthy volunteers. This study reveals the effectiveness of the STAIR-EPI technique in detecting myelin loss in both MS lesions and NAWM in MS patients, a capability that could subsequently be applied in clinical MRI scanners from all vendors. The implementation of the proposed STAIR-EPI sequence is relatively easy and requires neither specialized involvement from scanner vendors nor from application specialists.

EPI is one of the fastest MRI sequences and has already made significant contributions to clinical diagnosis and scientific investigation for various parts of the body including the brain, abdomen, and pelvis (41). With single-shot EPI, a complete set of spatial-encoding data can be gathered following a single RF excitation. However, single-shot EPI suffers from strong imaging distortion induced by eddy currents and B₀ inhomogeneity due to the low bandwidth in the phase-encoding direction. Multi-shot EPI strategy mitigates the imaging distortion because of its increased bandwidth in the phase-encoding direction. In this study, the STAIR technique was combined with the multi-shot EPI acquisition scheme to achieve relatively high-quality MWI. The image quality improved with more shots, but more shots also led to increased scan time (42). We found that eight shots provided a reasonable level of image quality within an acceptable 15-minute scan time.

One of the major advantages of the STAIR-EPI technique is its simplicity, given that it requires neither complex sequence implementation nor complicated post-processing in comparison to conventional techniques (24, 28–30, 37). Additionally, the STAIR preparation is relatively insensitive to B₀ and B₁ field inhomogeneities because it uses the AFP pulse for magnetization inversion (43). These benefits make the STAIR-EPI technique well-suited for clinical practice. Both DIR and STAIR are effective techniques for selective imaging of short T₁ MW and signal suppression of long T₁ intracellular and extracellular water in the brain (32, 37). However, the STAIR technique has an improved scan efficiency over the DIR technique because of its much shorter TR.

Previous research on the MWF quantification in NWM has presented a range of values using different methodologies (15–18, 23, 26, 44–49). For example, multicomponent T₂ decay analysis estimated MWFs ranging from 9% to 15.6% (15, 44–48), whereas multicomponent T₂* decay analysis yielded an MWF range of 6.9% to 14.4% (9, 16, 23, 26, 49). Labadie et al. employed multicomponent T₁ modeling and determined an MWF of 8.3% (18). Ma et al., employing the 3D STAIR-Cones technique, found an MWF value of 9.2% (37). Moreover, a range of MWF values has also been reported for MS lesions in previous MWI studies (15, 37, 48, 49). The multicomponent T₂ analysis indicated MWFs ranging from 1.7% to 6.4% (15, 48), while a multicomponent T₂* analysis determined an MWF of ∼0% (49). For the most recent STAIR-Cones study, Ma et al. reported an MWF value of 4.5% for MS lesions (37). In this study, the mean MWF values of NWM (i.e., 10 ± 1.3%) and MS lesions (i.e., 3.6 ± 1.3%) are consistent with those reported in previous research.

As reported in previous studies, the multicomponent T₂ relaxometry sequence took between 25 and 38 min to complete (45, 46), whereas the multicomponent T₂* relaxometry sequence took between 20 and 30 min (16, 26). In comparison, the total scan time for the proposed STAIR-EPI technique is around 16 min, which is relatively shorter than the typical multicomponent T₂ and T₂* relaxometry techniques.

There were some limitations in this study. First, only seven MS patients were scanned in this technical feasibility study. We plan to recruit more patients to investigate demyelination or remyelination in the future. Second, as proof of concept, a relatively large NEX (i.e., 30) was used in the STAIR-EPI scan to achieve a high SNR performance, significantly prolonging the scan time for whole brain coverage. The scan time could be reduced by using a lower NEX value (e.g., 10 or less). Moreover, the recent development of the denoising technique via deep learning could significantly increase the image SNR, thereby facilitating sufficient SNR improvement with a much reduced NEX (e.g., 5) (50, 51).

5. Conclusion

The STAIR-EPI technique detects demyelination in MS, facilitating easy clinical translation for the whole brain MWI.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving humans were approved by University of California San Diego. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin.

Author contributions

HS: Formal Analysis, Visualization, Writing – original draft, Data curation, Methodology, Writing – review & editing. DM: Formal Analysis, Visualization, Writing – original draft, Data curation, Methodology, Writing – review & editing. JA: Writing – review & editing, Data curation, Software. SS: Data curation, Writing – review & editing. JL: Data curation, Writing – review & editing. AS: Data curation, Writing – review & editing. BM: Writing – review & editing, Data curation. YM: Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article.

The authors acknowledge grant support from NIH (R01AR079484 and F32AG082458), as well as GE Healthcare. The authors declare that GE Healthcare was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. (2000) 343(13):938–52. doi: 10.1056/NEJM200009283431307

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Bean BP. The action potential in mammalian central neurons. Nat Rev Neurosci. (2007) 8(6):451–65. doi: 10.1038/nrn2148

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. (2001) 294(5547):1731–5. doi: 10.1126/science.1062960

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Steinman MDL. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. (1996) 85(3):299–302. doi: 10.1016/S0092-8674(00)81107-1

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Schmierer K, Wheeler-Kingshott CAM, Tozer DJ, Boulby PA, Parkes HG, Yousry TA, et al. Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation. Magn Reson Med. (2008) 59(2):268–77. doi: 10.1002/mrm.21487

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Dousset V, Grossman RI, Ramer KN, Schnall MD, Young LH, Gonzalez-Scarano F, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology. (1992) 182(2):483–91. doi: 10.1148/radiology.182.2.1732968

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Newcombe J, Hawkins CP, Henderson CL, Patel HA, Woodroofe MN, Hayes GM, et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain J Neurol. (1991) 114(Pt 2):1013–23. doi: 10.1093/brain/114.2.1013

CrossRef Full Text | Google Scholar

8. Filippi M, Rocca MA. MR Imaging of multiple sclerosis. Radiology. (2011) 259(3):659–81. doi: 10.1148/radiol.11101362

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Alonso-Ortiz E, Levesque IR, Pike GB. MRI-based myelin water imaging: a technical review. Magn Reson Med. (2015) 73(1):70–81. doi: 10.1002/mrm.25198

PubMed Abstract | CrossRef Full Text | Google Scholar

10. MacKay AL, Laule C. Magnetic resonance of myelin water: an in vivo marker for myelin. Brain Plast Amst Neth. (2016) 2(1):71–91. doi: 10.3233/BPL-160033

CrossRef Full Text | Google Scholar

11. Lee J, Hyun JW, Lee J, Choi EJ, Shin HG, Min K, et al. So you want to image myelin using MRI: an overview and practical guide for myelin water imaging. J Magn Reson Imaging JMRI. (2021) 53(2):360–73. doi: 10.1002/jmri.27059

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Piredda GF, Hilbert T, Thiran JP, Kober T. Probing myelin content of the human brain with MRI: a review. Magn Reson Med. (2021) 85(2):627–52. doi: 10.1002/mrm.28509

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Does MD. Inferring brain tissue composition and microstructure via MR relaxometry. NeuroImage. (2018) 182:136–48. doi: 10.1016/j.neuroimage.2017.12.087

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Möller HE, Bossoni L, Connor JR, Crichton RR, Does MD, Ward RJ, et al. Iron, myelin, and the brain: neuroimaging meets neurobiology. Trends Neurosci. (2019) 42(6):384–401. doi: 10.1016/j.tins.2019.03.009

CrossRef Full Text | Google Scholar

15. MacKay A, Whittall K, Adler J, Li D, Paty D, Graeb D. In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med. (1994) 31(6):673–7. doi: 10.1002/mrm.1910310614

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Du YP, Chu R, Hwang D, Brown MS, Kleinschmidt-DeMasters BK, Singel D, et al. Fast multislice mapping of the myelin water fraction using multicompartment analysis of T2* decay at 3T: a preliminary postmortem study. Magn Reson Med. (2007) 58(5):865–70. doi: 10.1002/mrm.21409

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Deoni SCL, Rutt BK, Arun T, Pierpaoli C, Jones DK. Gleaning multicomponent T1 and T2 information from steady-state imaging data. Magn Reson Med. (2008) 60(6):1372–87. doi: 10.1002/mrm.21704

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Labadie C, Lee JH, Rooney WD, Jarchow S, Aubert-Frécon M, Springer CS Jr, et al. Myelin water mapping by spatially regularized longitudinal relaxographic imaging at high magnetic fields. Magn Reson Med. (2014) 71(1):375–87. doi: 10.1002/mrm.24670

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Laule C, Leung E, Lis DKB, Traboulsee AL, Paty DW, MacKay AL, et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler Houndmills Basingstoke Engl. (2006) 12(6):747–53. doi: 10.1177/1352458506070928

CrossRef Full Text | Google Scholar

20. Laule C, Kozlowski P, Leung E, Li DKB, Mackay AL, Moore GRW. Myelin water imaging of multiple sclerosis at 7 T: correlations with histopathology. NeuroImage. (2008) 40(4):1575–80. doi: 10.1016/j.neuroimage.2007.12.008

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Laule C, Vavasour IM, Moore GRW, Oger J, Li DKB, Paty DW, et al. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study. J Neurol. (2004) 251(3):284–93. doi: 10.1007/s00415-004-0306-6

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Kolind S, Matthews L, Johansen-Berg H, Leite MI, Williams SCR, Deoni S, et al. Myelin water imaging reflects clinical variability in multiple sclerosis. NeuroImage. (2012) 60(1):263–70. doi: 10.1016/j.neuroimage.2011.11.070

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Hwang D, Kim DH, Du YP. In vivo multi-slice mapping of myelin water content using T2* decay. NeuroImage. (2010) 52(1):198–204. doi: 10.1016/j.neuroimage.2010.04.023

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Prasloski T, Mädler B, Xiang QS, MacKay A, Jones C. Applications of stimulated echo correction to multicomponent T2 analysis. Magn Reson Med. (2012) 67(6):1803–14. doi: 10.1002/mrm.23157

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Lee D, Lee J, Lee J, Nam Y. Single-scan z-shim method for reducing susceptibility artifacts in gradient echo myelin water imaging. Magn Reson Med. (2018) 80(3):1101–9. doi: 10.1002/mrm.27127

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Shin HG, Oh SH, Fukunaga M, Nam Y, Lee D, Jung W, et al. Advances in gradient echo myelin water imaging at 3 T and 7 T. NeuroImage. (2019) 188:835–44. doi: 10.1016/j.neuroimage.2018.11.040

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Lee J, Choi JY, Shin D, Kim EY, Oh SH, Lee J. Exploring generalization capacity of artificial neural network for myelin water imaging. Investig Magn Reson Imaging. (2020) 24(4):207. doi: 10.13104/imri.2020.24.4.207

CrossRef Full Text | Google Scholar

28. Nam Y, Lee J, Hwang D, Kim DH. Improved estimation of myelin water fraction using complex model fitting. NeuroImage. (2015) 116:214–21. doi: 10.1016/j.neuroimage.2015.03.081

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Lankford CL, Does MD. On the inherent precision of mcDESPOT. Magn Reson Med. (2013) 69(1):127–36. doi: 10.1002/mrm.24241

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Zhang J, Kolind SH, Laule C, MacKay AL. Comparison of myelin water fraction from multiecho T2 decay curve and steady-state methods. Magn Reson Med. (2015) 73(1):223–32. doi: 10.1002/mrm.25125

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Deoni SCL, Matthews L, Kolind SH. One component? Two components? Three? The effect of including a nonexchanging “free” water component in multicomponent driven equilibrium single pulse observation of T1 and T2. Magn Reson Med. (2013) 70(1):147–54. doi: 10.1002/mrm.24429

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Oh SH, Bilello M, Schindler M, Markowitz CE, Detre JA, Lee J. Direct visualization of short transverse relaxation time component (ViSTa). NeuroImage. (2013) 83485–92. doi: 10.1016/j.neuroimage.2013.06.047

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, et al. T1, T2 relaxation and magnetization transfer in tissue at 3 T. Magn Reson Med. (2005) 54(3):507–12. doi: 10.1002/mrm.20605

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Lancaster JL, Andrews T, Hardies LJ, Dodd S, Fox PT. Three-pool model of white matter. J Magn Reson Imaging JMRI. (2003) 17(1):1–10. doi: 10.1002/jmri.10230

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Helms G, Hagberg GE. In vivo quantification of the bound pool T1 in human white matter using the binary spin-bath model of progressive magnetization transfer saturation. Phys Med Biol. (2009) 54(23):N529–540. doi: 10.1088/0031-9155/54/23/N01

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Rioux JA, Levesque IR, Rutt BK. Biexponential longitudinal relaxation in white matter: characterization and impact on T1 mapping with IR-FSE and MP2RAGE. Magn Reson Med. (2016) 75(6):2265–77. doi: 10.1002/mrm.25729

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Ma YJ, Jang H, Lombardi AF, Corey-Bloom J, Bydder GM. Myelin water imaging using a short-TR adiabatic inversion-recovery (STAIR) sequence. Magn Reson Med. (2022) 88(3):1156–69. doi: 10.1002/mrm.29287

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Larson PEZ, Conolly SM, Pauly JM, Nishimura DG. Using adiabatic inversion pulses for long-T2 suppression in ultra-short echo time (UTE) imaging. Magn Reson Med. (2007) 58(5):952–61. doi: 10.1002/mrm.21341

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Horch RA, Gochberg DF, Nyman JS, Does MD. Clinically-compatible MRI strategies for discriminating bound and pore water in cortical bone. Magn Reson Med. (2012) 68(6):1774–84. doi: 10.1002/mrm.24186

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Sussman MS, Pauly JM, Wright GA. Design of practical T2-selective RF excitation (TELEX) pulses. Magn Reson Med. (1998) 40(6):890–9. doi: 10.1002/mrm.1910400615

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Poustchi-Amin M, Mirowitz SA, Brown JJ, McKinstry RC, Li T. Principles and applications of echo-planar imaging: a review for the general radiologist. Radiogr Rev Publ Radiol Soc N Am Inc. (2001) 21(3):767–79. doi: 10.1148/radiographics.21.3.g01ma23767

CrossRef Full Text | Google Scholar

42. An H, Ma X, Pan Z, Guo H, Lee EYP. Qualitative and quantitative comparison of image quality between single-shot echo-planar and interleaved multi-shot echo-planar diffusion-weighted imaging in female pelvis. Eur Radiol. (2020) 30(4):1876–84. doi: 10.1007/s00330-019-06491-3

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Tannús A, Garwood M. Adiabatic pulses. NMR Biomed. (1997) 10(8):423–34. doi: 10.1002/(sici)1099-1492(199712)10:8%3C423::aid-nbm488%3E3.0.co;2-x

CrossRef Full Text | Google Scholar

44. Kolind SH, Mädler B, Fischer S, Li DKB, MacKay AL. Myelin water imaging: implementation and development at 3.0 T and comparison to 1.5 T measurements. Magn Reson Med. (2009) 62(1):106–15. doi: 10.1002/mrm.21966

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Whittall KP, MacKay AL, Graeb DA, Nugent RA, Li DK, Paty DW. In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med. (1997) 37(1):34–43. doi: 10.1002/mrm.1910370107

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Nguyen TD, Wisnieff C, Cooper MA, Kumar D, Raj A, Spincemaille P, et al. T2 prep three-dimensional spiral imaging with efficient whole brain coverage for myelin water quantification at 1.5 tesla. Magn Reson Med. (2012) 67(3):614–21. doi: 10.1002/mrm.24128

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Prasloski T, Rauscher A, MacKay AL, Hodgson M, Vavasour IM, Laule C, et al. Rapid whole cerebrum myelin water imaging using a 3D GRASE sequence. NeuroImage. (2012) 63(1):533–9. doi: 10.1016/j.neuroimage.2012.06.064

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Oh J, Han ET, Pelletier D, Nelson SJ. Measurement of in vivo multi-component T2 relaxation times for brain tissue using multi-slice T2 prep at 1.5 and 3 T. Magn Reson Imaging. (2006) 24(1):33–43. doi: 10.1016/j.mri.2005.10.016

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Lenz C, Klarhöfer M, Scheffler K. Feasibility of in vivo myelin water imaging using 3D multigradient-echo pulse sequences. Magn Reson Med. (2012) 68(2):523–8. doi: 10.1002/mrm.23241

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Chen Z, Pawar K, Ekanayake M, Pain C, Zhong S, Egan GF. Deep learning for image enhancement and correction in magnetic resonance imaging—state-of-the-art and challenges. J Digit Imaging. (2023) 36(1):204–30. doi: 10.1007/s10278-022-00721-9

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Tamada D. Review: Noise and artifact reduction for MRI using deep learning. Published online February 28, 2020. doi: 10.48550/arXiv.2002.12889.